David Brankow

4.9k citations
24 papers · 3.0k · 2 hit papers · h-index 19

Impact in

    • Carcinogens and Genotoxicity Assessment
  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Cancer-related Molecular Pathways

Papers in

    • bioluminescence and chemiluminescence research 2
    • Glycosylation and Glycoproteins Research 2
    • Chemical Synthesis and Analysis 2
    • HER2/EGFR in Cancer Research 5

David Brankow

24 papers receiving 2.8k citations

David Brankow's Hit Papers

Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. 1973 · 1.0k citations
1.0k0+17+35Years since publication2505007501000

Peers

David Brankow
Comparison fields: 5 of 120
  • Cancer Research 645
  • Oncology 659
  • Molecular Biology 1.6k
  • Immunology 425
  • Immunology and Allergy 114
Replace Joseph Fargnoli with:
Joseph Fargnoli United States
Susan S. Leong United States
Daniel J. Noonan United States
Vladimir N. Ivanov United States
Catherine A. Reznikoff United States
Thomas G. Pretlow United States
Urs Eppenberger Switzerland
Joe W. Grisham United States
Junji Magae Japan
Sankar Addya United States
David Brankow relative to Joseph Fargnoli United States Joseph Fargnoli's profile →
Citations per field
00.5×1.5×
Joseph Fargnoli · 1×
Citations per year

Countries citing papers authored by David Brankow

Since Specialization
Citations

This map shows the geographic impact of David Brankow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Brankow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Brankow more than expected).

Fields of papers citing papers by David Brankow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Brankow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Brankow. The network helps show where David Brankow may publish in the future.

Co-authors

The 25 scholars most cited alongside David Brankow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Brankow Line = papers co-authored together David Brankow links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division.
Hit paper breakdown →
19731002
2
Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division.
Hit paper breakdown →
1973718
3 1992257
4
Two-stage chemical oncogenesis in cultures of C3H/10T1/2 cells.
1976242
5 2000117
6 2001101
7 199580
8 199565
9 199462
10 197855
11 199748
12
Effects of promoters on DNA synthesis in C3H/10T1/2 mouse fibroblasts.
197747
13 200946
14 199538
15 198937
16 199633
17 199232
18 199825
19 198621
20 198714

About David Brankow

David Brankow is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Genetics, having authored 24 papers that have together received 3.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cell Adhesion Molecules Research (3 papers), Virus-based gene therapy research (3 papers), bioluminescence and chemiluminescence research (2 papers), Glycosylation and Glycoproteins Research (2 papers), Chemical Synthesis and Analysis (2 papers) and 3D Printing in Biomedical Research (2 papers). The work is most often cited by research in Cancer Research (645 citations), Oncology (659 citations), Molecular Biology (1.6k citations), Immunology (425 citations) and Immunology and Allergy (114 citations). David Brankow has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Charles Heidelberger, Catherine A. Reznikoff, John S. Bertram, Sukdeb Mondal, Sylvia Hu, Francis H. Martin, K A Smith, Daniel Williams, Deniz Toksoz and Sidney V. Suggs. Their work appears in journals such as Carcinogenesis, Journal of Biological Chemistry, Science, Blood and Journal of Cellular Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact